MariMed's Ryan Crandall converts award to 32,812 shares

The grant has remaining vesting installments of 32,813 RSUs in January 2027 and 32,812 in April 2027.

Rhea-AI Filing Summary

Marimed Inc. (MRMD) Chief Commercial Officer Ryan Crandall exercised 32,812 restricted stock units on October 15, 2026, converting them one-for-one into common stock. The issuer withheld 9,631 common shares to satisfy tax obligations tied to vesting, reported at $0.06 per share. Crandall's reported post-transaction position was 65,625 RSUs.

Insider Trade Summary

32,812 shares exercised/converted

Exercise 3 txns

Insider Crandall Ryan

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU) F1, F3	32,812	$0.00	$0.00
Exercise	Common stock F1	32,812	$0.00	$0.00
Tax Withholding	Common stock F2	9,631	$0.06	$577.86

Holdings After Transaction: Restricted Stock Units (RSU) — 65,625 contracts (Direct); Common stock — 1,151,378 shares (Direct)

Footnotes (3)

1. F1. RSUs convert to shares of common stock on a one-for-one basis.
2. F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. F3. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest as follows: 32,813 on January 15, 2027 and 32,812 on April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Key Figures

RSUs exercised: 32,812 RSUs Shares withheld for tax obligations: 9,631 common shares Reported per-share price: $0.06 per share +3 more

6 metrics

RSUs exercised 32,812 RSUs October 15, 2026; converted one-for-one into common stock

Shares withheld for tax obligations 9,631 common shares RSU vesting on October 15, 2026

Reported per-share price $0.06 per share Shares withheld for tax obligations

Post-transaction RSU position 65,625 shares Reported after the October 15, 2026 transaction

Scheduled vesting 32,813 RSUs January 15, 2027

Scheduled vesting 32,812 RSUs April 15, 2027

Key Terms

one-for-one basis, tax withholding obligations, vesting

3 terms

one-for-one basis financial

"RSUs convert to shares of common stock on a one-for-one basis."

tax withholding obligations financial

"to satisfy tax withholding obligations in connection with the vesting of RSUs"

vesting financial

"the remaining RSUs under this grant will vest"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs did MRMD Chief Commercial Officer Ryan Crandall exercise?

Ryan Crandall exercised 32,812 RSUs on October 15, 2026, converting them one-for-one into common stock. His reported post-transaction RSU position was 65,625 shares.

How many MRMD shares were withheld for Ryan Crandall's RSU taxes?

The issuer withheld 9,631 common shares to satisfy tax withholding obligations in connection with RSU vesting on October 15, 2026; the transaction was reported at $0.06 per share.

When are the remaining MRMD RSUs scheduled to vest?

The remaining RSUs under the grant are scheduled to vest 32,813 on January 15, 2027 and 32,812 on April 15, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 06:50 PM EDT Accepted by SEC EDGAR 10/15/2026 - 06:49 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Crandall Ryan

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD MASSACHUSETTS 02062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	10/15/2026		M		32,812	A	$0(1)	1,161,009	D
Common stock	10/15/2026		F		9,631(2)	D	$0.06	1,151,378	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	10/15/2026		M			32,812	(3)	(3)	Common Stock, par value $.001 per share	32,812	$0	65,625	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest as follows: 32,813 on January 15, 2027 and 32,812 on April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Ryan Crandall	10/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)